3D Medicines Inc. discloses that the authorized share capital remained at 500 million ordinary shares, each with a par value of HKD 0.001, reflecting a total of HKD 500,000 as of November 30, 2025. The issued share count also remained unchanged at 258,177,000 ordinary shares, with no treasury shares reported.
The share option scheme continued to have 12,802,850 outstanding options at the end of the month, without new share issuances or transfers. No funds were raised from the exercise of any options during this period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments